Showing results (71-80 of 123) with videos related to
Sort By:
Pageof 13
Human Molecular Genetics|September 1, 1993
Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assayA J Linnenbach, L B Pressler, B A Seng, et al.The Journal of Urology|November 17, 1998
The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.Urology|April 1, 1997
Development of prostate cancer after pituitary dysfunction: a report of 8 patientsD W Ebling, J Ruffer, R Whittington, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 20, 1999
Glutathione S-transferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancerT R Rebbeck, A H Walker, J M Jaffe, et al.International Journal of Radiation Oncology, Biology, Physics|October 23, 1997
The use of combined radiation therapy and hormonal therapy in the management of lymph node-positive prostate cancerR Whittington, S B Malkowicz, M Machtay, et al.International Journal of Radiation Oncology, Biology, Physics|March 15, 1997
Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/mlA V D'Amico, R Whittington, I Kaplan, et al.American Journal of Clinical Oncology|June 1, 1996
A pilot trial of 5-FU, leucovorin, and cisplatin with or without adriamycin in advanced cancerD J Vaughn, N J Meropol, B Armstead, et al.International Journal of Radiation Oncology, Biology, Physics|September 30, 1994
A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.Urology|March 29, 2000
Combination of the preoperative PSA level, biopsy gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.DNA and Cell Biology|November 22, 2002
KIAA1096, a gene on chromosome 1q, is amplified and overexpressed in bladder cancerWilliam C Huang, Sherry Taylor, Trang B Nguyen, et al.Pageof 13